2
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
195
Neoplasm Metastasis
22
Prostatic Neoplasms, Castration-Resistant
20
Breast Neoplasms
19
Neoplasms
18
Metastatic Castration Resistant Prostate Cancer
10
Prostate Cancer Metastatic
7
Metastatic Castration-Resistant Prostate Cancer
7
Triple Negative Breast Neoplasms
6
Metastatic Castration-resistant Prostate Cancer
6
Parkinson Disease 4, Autosomal Dominant Lewy Body
5
Pancreatic Neoplasms
5
Colorectal Neoplasms
5
Castration-resistant Prostate Cancer
5
Carcinoma, Non-Small-Cell Lung
5
Melanoma
4
Carcinoma, Hepatocellular
4
Bulbo-Spinal Atrophy, X-Linked
4
Adenocarcinoma
4
Urinary Bladder Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Small Cell Lung Carcinoma
3
Prostate Adenocarcinoma
3
Ovarian Neoplasms
3
Carcinoma, Renal Cell
3
mCRPC
2
Uterine Cervical Neoplasms
2
Recurrence
2
Prostatic Diseases
2
Non-metastatic Castration-resistant Prostate Cancer
2
Interventions
Cognitive Behavioral Therapy
30
Acupuncture Therapy
6
Surveys and Questionnaires
4
Behavior Therapy
4
Standard of Care
3
Electroacupuncture
3
Control Groups
3
Breathing Exercises
3
Aromatherapy
3
suvorexant
2
Zolpidem
2
Yoga
2
Saline Solution
2
Modafinil
2
Mindfulness-Based Stress Reduction
2
Exercise
2
zopiclone
1
ziprasidone
1
ramelteon
1
pegfilgrastim
1
enzalutamide
1
darolutamide
1
cyclobenzaprine
1
apalutamide
1
Water
1
Warfarin
1
Vecuronium Bromide
1
Vancomycin
1
Uncertainty
1
Tranexamic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sleep Initiation and Maintenance Disorders
×
enzalutamide
×
Clear all
NCT07181122
2026-04-28
PRO-MIND
Ankara Etlik City Hospital
Recruiting
102 enrolled